Regulation of FLT3 and its ligand in normal hematopoietic progenitor cells

Annals of Hematology

Volumn 88, Issue 3, 2009, Pages 203-211

  Weisel, Katja C ^a   Yildirim, Sedat ^a   Schweikle, Eric ^a   Kanz, Lothar ^a   Möhle, Robert ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Expansion; FL; FLT3; Hematopoiesis

Indexed keywords

CD135 ANTIGEN; CYTOKINE; FLT3 LIGAND; IMATINIB; LESTAURTINIB; NEUTRALIZING ANTIBODY;

APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; BLOOD TOXICITY; CD34 SELECTION; CELL COUNT; CELL EXPANSION; CELL GROWTH; CELL LINEAGE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ACTIVATED CELL SORTING; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; INHIBITION KINETICS; LIQUID CULTURE; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEIN SYNTHESIS; REGULATORY MECHANISM;

CARBAZOLES; CELL PROLIFERATION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; FMS-LIKE TYROSINE KINASE 3; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; MEMBRANE PROTEINS;

EID: 59049101551     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-008-0605-6     Document Type: Article

References (33)

1. Kondo M, Wagers AJ, Manz MG, Prohaska SS, Scherer DC, Beilhack GF et al (2003) Biology of hematopoietic stem cells and progenitors: Implications for clinical application. Annu Rev Immunol 21:759-806 doi: 10.1146/ annurev.immunol.21.120601.141007
2. Parcells BW, Ikeda AK, Simms-Waldrip T, Moore TB, Sakamoto KM (2006) FLT3 in normal hematopoiesis and acute myeloid leukemia. Stem Cells 24:1174-1184 doi: 10.1634/stemcells.2005-0519
3. Gilliland DG, Griffin JD (2002) The roles of FLT3 in hematopoiesis and leukemia. Blood 100:1532-1542 doi: 10.1182/blood-2002-02-0492
4. Mathews LS, Vale WW (1991) Expression cloning of an activin receptor, a predicted transmembrane serin kinase. Cell 65:973-982 doi: 10.1016/ 0092-8674(91)90549-E
5. Rosnet O, Mattei MG, Marchetto S, Birnbaum D (1991) Isolation and chromosomal localization of a novel FMS-like tyrosine kinase. Genomics 9:380-385 doi: 10.1016/0888-7543(91)90270-O
6. Rosnet O, Schiff C, Pebusque MJ et al (1993) Human FLT3/FLK2 gene: CDNA cloning and expression in hematopoietic cells. Blood 82:1110-1119
7. Lyman SD, Jacobsen SE (1998) c-kit Ligand and Flt3 ligand: Stem/ progenitor factors with overlapping yet distinct activities. Blood 91:1101-1134
8. Adolfsson J, Mansson R, Buza-Vidas N et al (2005) Identification of Flt3+ lympho-myeloid stem cells lacking erythro-megakaryocytic potential. A revised road map for adult blood lineage commitment. Cell 121:295-306 doi: 10.1016/j.cell.2005.02.013
9. Adolfsson J, Borge OJ, Bryder D et al (2001) Upregulation of Flt3 expression within the bone marrow Lin(-)Sca1(+)c-kit(+) stem cell compartment is accompanied by loss of self-renewal capacity. Immunity 15:659-669 doi: 10.1016/S1074-7613(01)00220-5
10. + human bone marrow cells and is involved in the proliferation of early progenitor/ stem cells. Proc Natl Acad Sci USA 91:459-463 doi: 10.1073/pnas.91.2.459
11. + hematopoietic stem cells capable of multilineage engrafting NOD/SCID mice express flt3: Distinct flt3 and c-kit expression and response patterns on mouse and candidate human hematopoietic stem cells. Blood 102:881-886 doi: 10.1182/ blood-2002-06-1694
12. + progenitors to sustain long-term hematopoiesis in immune-deficient mice after ex vivo retroviral transduction. Blood 89:446-456
13. Breems DA, Blockland EA, Neben S, Ploemacher RE (1994) Frequency analysis of human primitive haematopoietic stem cells subsets using a cobblestone area forming cell assay. Leukemia 8:1095-1104
14. Rappold I, Ziegler BL, Köhler I, Marchetto S, Rosnet O, Birnbaum D et al (1997) Functional and phenotypic characterization of cord blood and bone marrow subsets expressing FLT3 (CD135) receptor tyrosine kinase. Blood 90:111-125
15. Hannum C, Culpepper J, Campbell D et al (1994) Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs. Nature 368:643-648 doi: 10.1038/368643a0
16. Lyman SD, James L, Johnson L et al (1994) Cloning of the human homologue of the murine flt3 ligand: A growth factor for early hematopoietic progenitor cells. Blood 83:2795-2801
17. Brasel K, Escobar S, Anderberg R, deVries P, Gruss HJ, Lyman SD (1995) Expression of the flt-3 receptor and its ligand on hematopoietic cells. Leukemia 9:1212-1218
18. Lyman SD, Brasel K, Rousseau AM, Williams DE (1994) The flt3 ligand: A hematopoietic stem cell factor whose activities are distinct from steel factor. Stem Cells 12:99-107
19. Ray RJ, Paige CJ, Furlanger C, Lyman SD, Rotapel R (1996) Flt3 ligand supports the differentiation of early B-cell progenitors in the presence of interleukin-11 and interleukin-7. Eur J Immunol 26:1504-1510 doi: 10.1002/eji.1830260715
20. Piacibello W, Sanavio F, Garetto L et al (1997) Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood. Blood 89:2644-2653
21. -) human hematopoietic cells: Novel responses to FLT3-ligand and thrombopoietin. J Exp Med 18:2551-2558 doi: 10.1084/jem.183.6.2551
22. Birg F, Rosnet O, Carbuccia N, Birnbaum D (1994) The expression of FMS, KIT and FLT3 in hematopoietic malignancies. Leuk Lymphoma 13:223-227 doi: 10.3109/10428199409056285
23. Zheng R, Levis M, Piloto O et al (2004) FLT3 ligand causes autocrine signaling in acute myeloid leukemia cells. Blood 103:267-274 doi: 10.1182/blood-2003-06-1969
24. Levis M, Small D (2003) FLT3: It does matter in leukemia. Leukemia 17:1738-1752 doi: 10.1038/sj.leu.2403099
25. Levis M, Allenbach J, Tse KF et al (2002) A FLT3-targeted tyrosine kinase inhibitor is cytotoxic to leukemia cells in vitro and in vivo. Blood 99:3885-3891 doi: 10.1182/blood.V99.11.3885
26. Brown P, Meshinchi S, Levis M, Alonzo TA, Gerbing R, Lange B et al (2004) Pediatric AML primary samples with FLT3/ITD mutations are preferentially killed by FLT3 inhibition. Blood 104:1841-1849 doi: 10.1182/blood-2004-03-1034
27. Brown P, Levis M, Shurtleff S, Campana D, Downing J, Small D (2005) FLT3 inhibition selectively kills childhood acute lymphoblastic leukemia cells with high levels of FLT3 expression. Blood 105:812-820 doi: 10.1182/blood-2004-06-2498
28. Smith DM, Levis M, Beran M, Giles F, Kanarjian H, Berg K et al (2004) Single-agent CEP-701, a novel FLT3 inhibitor, shows biologic and clinical activity in patients with relapsed or refractory acute myeloid leukemia. Blood 103:3669-3676 doi: 10.1182/blood-2003-11-3775
29. Bartolovic K, Balabanov S, Hartmann U, Komor M, Bühring HJ, Möhle R et al (2004) Inhibitory effect of imatinib on normal progenitor cells in vitro. Blood 103:523-529 doi: 10.1182/ blood-2003-05-1535
30. Van Hennink PB, Verstegen MM, Bierhuizen MF, Limon A, Wognum AW, Cancelas JA et al (1998) Highly efficient transduction of the green fluorescent protein gene in human umbilical cord blood stem cells capable of cobblestone formation in long-term cultures and multilineage engraftment of immunodeficient mice. Blood 92:4013-4022
31. Moore MAS (2003) In vitro and in vivo hematopoiesis. In: Zucker-Franklin D, Greaves MF, Grossi CE, Marmont AM (eds) Atlas of blood cells: Function and pathology. 3rd edn. Arti Grafiche Salea, Milan, pp 1-38
32. Shivdasani RA, Orkin SH (1996) The transcriptional control of hematopoiesis. Blood 87:4025-4039
33. Zhu J, Emmerson SG (2002) Hematopoietic cytokines, transcription factors and lineage commitment. Oncogene 21:3295-3313 doi: 10.1038/sj.onc.1205318